Abstract: This article elaborates on the structure and function of CD81, explores its role and value in malignant solid and hematological tumors, introduces CD81-related antibodies and small-molecule compounds, analyzes the advantages and challenges faced by anti-CD81 therapy in clinical applications, and looks forward to the future application prospects of anti-CD81 therapy in the treatment of malignant hematological diseases.